Cargando…

Intravenous Iron Administration and Hypophosphatemia in Clinical Practice

Introduction. Parenteral iron formulations are frequently used to correct iron deficiency anemia (IDA) and iron deficiency (ID). Intravenous formulation efficacy on ferritin and hemoglobin level improvement is greater than that of oral formulations while they are associated with lower gastrointestin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardy, S., Vandemergel, X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426778/ https://www.ncbi.nlm.nih.gov/pubmed/26000018 http://dx.doi.org/10.1155/2015/468675

Ejemplares similares

Recurrent severe hypophosphatemia following intravenous iron administration
por: Nataatmadja, Melissa Stephanie, et al.
Publicado: (2020)

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
por: Glaspy, John A., et al.
Publicado: (2021)

Intravenous Iron Induced Severe Hypophosphatemia
por: Guo, Rong R, et al.
Publicado: (2021)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review
por: Glaspy, John A, et al.
Publicado: (2020)

Sharp rises in FGF23 and hypophosphatemia after intravenous iron administration do not cause myocardial damage
por: Brandenburg, Vincent, et al.
Publicado: (2020)

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
por: Schaefer, Benedikt, et al.
Publicado: (2016)

Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials
por: Fukumoto, Seiji, et al.
Publicado: (2023)

MON-338 Severe Hypophosphatemia Induced by Intravenous Ferric Carboxymaltose Therapy for Iron Deficiency Anemia
por: Tam, Matthew, et al.
Publicado: (2020)

Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact
por: Detlie, Trond Espen, et al.
Publicado: (2021)

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
por: Fang, Wendy, et al.
Publicado: (2019)

Intravenous Irons: From Basic Science to Clinical Practice
por: Bhandari, Sunil, et al.
Publicado: (2018)

Point-of-Care Ultrasound (POCUS) in the Field of Diabetology
por: Vandemergel, X.
Publicado: (2021)

Hypophosphatemia in cancer patients
por: Adhikari, Shreedhar, et al.
Publicado: (2021)

A rare case of parental iron-induced persistent hypophosphatemia
por: Sullivan, Abigayle, et al.
Publicado: (2020)

98 Severe Hypophosphatemia After Iron Infusion: A Serious Complication
Publicado: (2021)

Severe hypophosphataemia after intravenous iron administration
por: Anand, Gurpreet, et al.
Publicado: (2017)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia
por: Högler, Wolfgang, et al.
Publicado: (2019)

Solitary Intrathyroid Metastasis Occurring 23 Years after Resection of Renal Cell Carcinoma
por: Vandemergel, X.
Publicado: (2021)

Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia
por: Weber, Thomas J, et al.
Publicado: (2022)

Severe Hypophosphatemia Occurring After Repeated Exposure to a Parenteral Iron Formulation
por: Haridas, Keerthana, et al.
Publicado: (2022)

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk
por: Ganz, Tomas, et al.
Publicado: (2020)

Impact of X-Linked Hypophosphatemia on Muscle Symptoms
por: Romagnoli, Cecilia, et al.
Publicado: (2022)

Tumor-induced hypophosphatemia
por: Mulani, M., et al.
Publicado: (2017)

Early postkidney transplantation hypophosphatemia
por: Ghorbani, Maryam, et al.
Publicado: (2020)

Significance of Hypophosphatemia in Patients with Pneumonia
por: Morimoto, Yasuhiro, et al.
Publicado: (2022)

Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review
por: Munns, Craig F, et al.
Publicado: (2023)

Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer
por: Masuda, Hiroshi, et al.
Publicado: (2017)

Evolution of Metabolic Abnormalities in Alcoholic Patients during Withdrawal
por: Vandemergel, X., et al.
Publicado: (2015)

Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo
por: Faria, Bernardo, et al.
Publicado: (2019)

Bleomycin-Induced Lung Injury After Intravenous Iron Administration
por: Saccone, Nicole, et al.
Publicado: (2022)

Tenofovir and Severe Symptomatic Hypophosphatemia
por: Kichloo, Asim, et al.
Publicado: (2019)

Hypophosphatemia in Patients With Multiple Myeloma
por: Cancarevic, Ivan, et al.
Publicado: (2023)

The Impact of Moderate Hypophosphatemia on the Clinical Management of Primary Hyperparathyroidism
por: Güneş, Elif, et al.
Publicado: (2023)

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial‐IRON Trial
por: Núñez, Julio, et al.
Publicado: (2020)

X-Linked Hypophosphatemia: A New Era in Management
por: Dahir, Kathryn, et al.
Publicado: (2020)

Hypersensitivity to Intravenous Iron Preparations
por: Caimmi, Silvia, et al.
Publicado: (2022)

Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice
por: Richards, Toby, et al.
Publicado: (2021)

Refeeding Hypophosphatemia in Adolescents With Anorexia Nervosa: A Systematic Review
por: O’Connor, Graeme, et al.
Publicado: (2013)

MON-491 Persistent Isolated Hypophosphatemia after Intravenous Ferric Carboxymaltose Infusion in a Patient with Total Gastrectomy
por: Bailey, Rosemary, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_msfpddfhuovfemskvvklki3njo